Figure 1 of Wang, Mol Vis 2015; 21:264-272.


Figure 1. Increased GM-CSF in vitreous was associated with the at-risk variants of the CFH Y402H polymorphism. The GM-CSF level differed significantly among donors with CC, CT, or TT variants of the CFH Y402H polymorphism (one-way ANOVA, p<0.01). The GM-CSF level was significantly higher in the vitreous from donors with CC and CT variants compared to that of donors with the protective TT variant (mean ± SEM, 607.54±85.83 pg/ml, n=4, 656.32±15.20 pg/ml, n=10 versus 286.69±81.96 pg/ml, n=8, respectively, post hoc Bonferroni multiple comparison test, *p<0.05).